Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H22O8 |
InChIKeyYJGVMLPVUAXIQN-XVVDYKMHSA-N |
CAS Registry518-28-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | US | 01 Dec 2016 | |
Solid tumor | Phase 1 | US | 01 Dec 2016 |
Phase 1 | - | (shtgdjchav) = kiyndkuvsw ygezyexzhj (cwcpnzeajz ) View more | Positive | 01 Dec 2024 |